Last reviewed · How we verify
NCT04236037
Ultrasound-guided Biopsy of the Pleura as a Supplement to Extraction of Fluid in Patients With One-sided Fluid in the Pleura
NA trial testing ultrasound-guided pleural biopsy in Malignant Pleural Effusion in 5 participants. Terminated before completion.
23 September 2020
Quick facts
| Lead sponsor | Naestved Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 5 |
| Start date | 11 November 2019 |
| Primary completion | 23 September 2020 |
| Estimated completion | 23 September 2020 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- ultrasound-guided pleural biopsy
- Thoracentesis
Conditions studied
- Malignant Pleural Effusion — all drugs for Malignant Pleural Effusion →
- Exudative Pleural Effusion — all drugs for Exudative Pleural Effusion →
Sponsor
Naestved Hospital
Who can join
18 and older, any sex, with Malignant Pleural Effusion or Exudative Pleural Effusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research group will investigate the diagnostic effect of early introduction of ultrasound guided pleural biopsy in the work-up of patients with one-sided pleural effusion, suspected of malignant pleural effusion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04236037
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malignant Pleural Effusion
Currently open trials in the same condition.
- NCT06421610 — OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. · Phase 1 · recruiting
- NCT05620329 — UNC Pleural Fluid Registry · recruiting
Other Naestved Hospital trials
Trials by the same sponsor.
- NCT06672757 — Use of App for Stroke Assessment VS Standard Level of Care During Prehospital Stroke Assessment · NA · not yet recruiting
- NCT05575700 — Safety of Ibuprofen After Major Orthopaedic Surgeries · Phase 4 · completed
- NCT05531370 — Implementation of Evidence-based Breathing Retraining for Patients with Asthma in Region Zealand · NA · active not recruiting
- NCT04806412 — Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study. · NA · unknown
- NCT04123873 — Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the Fi · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04236037 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Naestved Hospital
- Last refreshed: 25 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04236037.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing